Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Radiation Oncology (London, England)|July 10, 2021
Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel diseaseJonathan W Lischalk, Seth Blacksburg, Christopher Mendez, et al.
World Journal of Urology|June 27, 2018
Ablation energies for focal treatment of prostate cancerOlivia Lodeizen, Martijn de Bruin, Scott Eggener, et al.
Frontiers in Oncology|February 27, 2024
High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiationJonathan W Lischalk, Meredith Akerman, Michael C Repka, et al.
Annals of Surgery|April 17, 2026
Association Between Hospital Participation in the Global Budget Revenue Model and Surgical Outcomes Among Traditional Medicare Beneficiaries Undergoing Cancer SurgeryMeiling Ying, Xiwei Yang, Karen Joynt Maddox, et al.
Chemical Research in Toxicology|June 7, 2021
Use of Cause-and-Effect Analysis to Optimize the Reliability of <i>In Vitro</i> Inhalation Toxicity Measurements Using an Air-Liquid InterfaceElijah J Petersen, Monita Sharma, Amy J Clippinger, et al.
Radiation Oncology (London, England)|October 1, 2025
Fiducial tracking fidelity in robotic prostate SBRT: a comparison of a 3-fraction boost following pelvic nodal irradiation and definitive 5-fraction treatmentJonathan W Lischalk, Vianca F Santos, Brianna Vizcaino, et al.
Advances in Radiation Oncology|March 11, 2026
Magnetic Resonance Imaging-Directed Stereotactic Body Radiation Therapy Microboost in Concert With Pelvic Nodal Irradiation for Prostate Cancer in the Higher-Risk Spectrum: ToxicityMina Musthafa, Markus Wells, Timothy Kearney, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2025
High-volume biopsy core involvement is not associated with failure after SBRT monotherapy for intermediate-risk prostate cancerJoshua C Hurwitz, Jonathan A Haas, Vianca F Santos, et al.
Practical Radiation Oncology|November 20, 2023
Stereotactic Body Radiation Therapy for the Curative Treatment of Prostate Cancer in Ultralarge (≥100 cc) GlandsJoshua C Hurwitz, Jonathan Haas, Christopher Mendez, et al.
Radiation Oncology (London, England)|March 4, 2024
High-volume prostate biopsy core involvement is not associated with an increased risk of cancer recurrence following 5-fraction stereotactic body radiation therapy monotherapyJonathan W Lischalk, Astrid Sanchez, Vianca F Santos, et al.
Pageof 6